Abstract
In a prospective clinical and biochemical study of 16 patients treated with high doses of an immunoglobulin product that had been modified for intravenous use by mild pepsin treatment at pH 4 no evidence of hepatitis could be found. This contrasts with recent reports that intravenous immunoglobulin products can apparently transmit non-A, non-B hepatitis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bussel J. B., Hilgartner M. W. The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease. Br J Haematol. 1984 Jan;56(1):1–7. doi: 10.1111/j.1365-2141.1984.tb01266.x. [DOI] [PubMed] [Google Scholar]
- Dow B. C., Follett E. A., Mitchell R. Non-A, non-B hepatitis markers in the west of Scotland. Med Lab Sci. 1981 Oct;38(4):359–363. [PubMed] [Google Scholar]
- Fletcher M. L., Trowell J. M., Craske J., Pavier K., Rizza C. R. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J (Clin Res Ed) 1983 Dec 10;287(6407):1754–1757. doi: 10.1136/bmj.287.6407.1754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gerrits C. A West African epilepsy focus. Lancet. 1983 Feb 12;1(8320):358–358. doi: 10.1016/s0140-6736(83)91663-x. [DOI] [PubMed] [Google Scholar]
- Lane R. S. Non-A, non-B hepatitis from intravenous immunoglobulin. Lancet. 1983 Oct 22;2(8356):974–975. doi: 10.1016/s0140-6736(83)90496-8. [DOI] [PubMed] [Google Scholar]
- Lever A. M., Webster A. D., Brown D., Thomas H. C. Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin. Lancet. 1984 Nov 10;2(8411):1062–1064. doi: 10.1016/s0140-6736(84)91506-x. [DOI] [PubMed] [Google Scholar]
- Non-A, non-B hepatitis and intravenous immunoglobulin. Lancet. 1985 Feb 16;1(8425):404–405. [PubMed] [Google Scholar]
- Welch A. G., Cuthbertson B., McIntosh R. V., Foster P. R. Non-A, non-B hepatitis from intravenous immunoglobulin. Lancet. 1983 Nov 19;2(8360):1198–1199. doi: 10.1016/s0140-6736(83)91250-3. [DOI] [PubMed] [Google Scholar]